Real-time enrollment status for this rhabdomyosarcoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:21 AM UTC
| NCT Number | NCT06865664 |
| Recruiting Status | Recruiting |
| Condition | Rhabdomyosarcoma |
| Phase | PHASE1 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | March 16, 2026 (Mar 16, 2026) |
As of July 17, 2026: Clinical trial NCT06865664 is currently recruiting participants. This phase1 study for rhabdomyosarcoma is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06865664 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06865664 was last updated Mar 16, 2026 (March 16, 2026). HelloStudys verifies this status automatically.